Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway

Nitric Oxide - Biology and Chemistry

Volumn 10, Issue 1, 2004, Pages 25-35

  Wang, Ying ^a   Nagase, Sohji ^a   Koyama, Akio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelial nitric oxide synthase; Expression; IGF I; Nitric oxide; Phosphatidylinositol 3 kinase; Phosphorylation; Rat glomeruli; VEGF

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLOMERULUS; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; INSULIN-LIKE GROWTH FACTOR I; KIDNEY GLOMERULUS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 1642603531     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2004.02.001     Document Type: Article

References (34)

1. Tolins P., Shultz P.J., Raij L., Brown D.M., Mauer S.M. Abnormal renal hemodynamic response to reduced renal perfusion in diabetic rats: role of NO. Am. J. Physiol. 265:1993;F886-F895.
2. Reyes A.A., Karl I.E., Kissane J., Klahr S. L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J. Am. Soc. Nephrol. 4:1993;1039-1045.
3. Bank N., Aynedjian H.S. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int. 43:1993;1306-1312.
4. Sugimoto H., Shikata K., Matsuda M., Kushiro M., Hayashi Y., Hiragushi K., Wada J., Makino H. Increased expression of endothelial cell nitric oxide synthase (eNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia. 41:1998;1426-1434.
5. Veelken R., Hilgers K.F., Hartner A., Haas A., Böhmer K.P., Sterzel R.B. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J. Am. Soc. Nephrol. 11:2000;71-79.
6. De Vriese A.S., Stoenoiu M.S., Elger M., Devuyst O., Vanholder R., Kriz W., Lameire N.H. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide. Kidney Int. 60:2001;202-210.
7. Hiragushi K., Sugimoto H., Shikata K., Yamashita T., Miyatake N., Shikata Y., Wada J., Kumakai I., Fukushima M., Makino H. Nitric oxide system is involved in glomerular hyperfiltration in Japanese nomor-and micro-albuminuric patients with type 2 diabetes. Diabetes Res. Clin. Pract. 53:2001;149-159.
8. Tilton R.G., Chang K., Hasan K.S., Smith S.R., Petrash J.M., Misko T.P., Moore W.M., Currie M.G., Corbett J.A., McDaniel M.L., Williamson J.R. Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes. 42:1993;221-232.
9. Choi K.C., Lee S.C., Kim S.W., Kim N.H., Lee J.U., Kang Y.J. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin- induced diabetic rats. Korean J. Intern. Med. 14:1999;32-41.
10. Cooper M.E., Vranes D., Youssef S., Stacker S.A., Cox A.J., Rizkalla B., Casley D.J., Bach L.A., Kelly D.J., Gilbert R.E. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 48:1999;2229-2239.
11. Cruz M.C.I., Ziyadeh F.N., Isono M., Kouahou M., Han D.C., Kalluri R., Mundel P., Chen S. Effect of high glucose and TGF-β 1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int. 62:2002;901-913.
12. Vriese A.S.D., Tilton R.G., Elger M., Stephan C.C., Kriz W., Lameire N.H. Antibodies against vascular endothelial growth factor improved early renal disfunction in experimental diabetes. J. Am. Soc. Nephrol. 12:2001;993-1000.
13. Hammerman M.R. The growth hormone-insulin-like growth factor axis in kidney. Am. J. Physiol. 257:1989;F503-F514.
14. Zumkeller W., Schofield P.N. The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney. Virchows Arch. B Cell Pathol. 62:1992;207-220.
15. Guler H.P., Eckardt K.U., Zapf J., Bauer C., Froesch E.R. Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man. Acta Endocrinol. (Copenh.). 121:1989;101-106.
16. Baumann U., Eisenhauer T., Hartmann H. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor I during euglycaemic clamping in anaesthetized rats. Eur. J. Clin. Invest. 22:1992;204-209.
17. Hirschberg R., Adler S. Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications. Am. J. Kidney Dis. 31:1998;901-919.
18. Flyvbjerg A., Bornfeldt K.E., Marshall S.M., Arnqvist H.J., Ørskov H. Kidney IGF-1 mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia. 33:1990;335-338.
19. Segev Y., Landau D., Marbach M., Shehadeh N., Flyvbjerg A., Phillip M. Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor-1. J. Am. Soc. Nephrol. 8:1997;436-444.
20. Haylor J., Singh I., el Nahas A.M. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int. 39:1991;333-335.
21. Schlondorff D. Preparation and study of isolated glomeruli. Methods Enzymol. 191:1990;130-140.
22. Kawai N., Bloch D.B., Filippov G., Rabkina D., Snen H.C., Losty P.D., Janssen S.P., Zapol W.M., de la Monte S., Bloch K.D. Constitutive endothelial nitric oxide synthase gene expression is regulated during lung development. Am. J. Physiol. 268(4 Pt 1):1995;L589-L595.
23. Briggs J.P., Todd-Turla K., Schnermann J.B., Killen P.D. Approach to the molecular basis of nephron heterogeneity: application of reverse transcription-polymerase chain reaction to dissected tubule segments. Semin. Nephrol. 13:1993;2-12.
24. Malinski T., Radomski M.W., Taha Z., Moncada S. Direct electrochemical measurement of nitric oxide released from human platelets. Biochem. Biophys. Res. Commun. 194:1993;960-965.
25. Tsukahara H., Gordienko D.V., Goligorsky M.S. Continuously monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 193:1993;722-729.
26. Trachtman H., Futterweit S., Franki N., Singhal P.C. Effect of vascular endothelial growth factor on nitric oxide production by cultured mesangial cells. Biochem. Biophys. Res. Commun. 245:1998;443-446.
27. Bouloumié A., Schini-Kerth V.B., Busse R. Vascular endothelial growth factor up regulates nitric oxide synthase expression in endothelial cells. Cardiovasc. Res. 41:1999;773-780.
28. J.D. Hood, C.J. Meininger, M. Ziche, H.J. Granger, VEGF upregulates eNOS message, protein, and NO production in human endothelial cells, Am. J. Physiol. 274 (Heart Circ. Physiol. 43) (1998) H1054-H1058
29. Shen B.Q., Lee D.Y., Zioncheck T.F. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J. Biol. Chem. 274:1999;33057-33063.
30. Park J.S., Hong G.R., Baek S.W., Shin D.G., Kim Y.J., Shim B.S. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells. J. Korean Med. Sci. 17:2002;161-167.
31. Guo D., Jia Q., Song H.Y., Donner D. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:1995;6729-6733.
32. Conti F.G., Striker L.J., Lesniak M.A., Mackay K., Roth J., Striker G.E. Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology. 122:1988;2788-2795.
33. Conti F.G., Elliot S.J., Striker L.J., Striker G.E. Binding of insulin-like growth factor I by glomerular endothelial and epithelial cells: further evidence for IGF-I action in the renal glomerulus. Biochem. Biophys. Res. Commun. 163:1989;952-958.
34. Zeng G.Y., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J. Clin. Invest. 98:1996;894-898.